<http://webisa.webdatacommons.org/250687858>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/286661191>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/250687858> .
<http://webisa.webdatacommons.org/250687858>	<http://www.w3.org/ns/prov#value>	"FDA cites particular challenges including the fact that there are a large number of products marketed for which there is not a final monograph available." .
<http://webisa.webdatacommons.org/250687858>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<eyeonfda.com> .